Results 221 to 230 of about 2,419,473 (338)

[Implementation of an early HIV diagnosis and treatment program in a hospital emergency department]. [PDF]

open access: yesAn Sist Sanit Navar
Martínez Faya H   +5 more
europepmc   +1 more source

Early metastasis is characterized by Gr1+ cell dysregulation and is inhibited by immunomodulatory nanoparticles

open access: yesMolecular Oncology, EarlyView.
Breast cancer metastasis is associated with myeloid cell dysregulation and the lung‐specific accumulation of tumor‐supportive Gr1+ cells. Gr1+ cells support metastasis, in part, through a CHI3L1‐mediated mechanism, which can be targeted and inhibited with cargo‐free, polymeric nanoparticles.
Jeffrey A. Ma   +9 more
wiley   +1 more source

Semiotica per campagne di digital marketing. Alcune proposte operative

open access: yesOcula
This work is part of the extensive series of semiotic studies that, from the late 1980s to the present, have dialogued with the most diverse areas of marketing, up to the most recent digital marketing.
Giovanna Cosenza
doaj  

Detecting homologous recombination deficiency for breast cancer through integrative analysis of genomic data

open access: yesMolecular Oncology, EarlyView.
This study develops a semi‐supervised classifier integrating multi‐genomic data (1404 training/5893 validation samples) to improve homologous recombination deficiency (HRD) detection in breast cancer. Our method demonstrates prognostic value and predicts chemotherapy/PARP inhibitor sensitivity in HRD+ tumours.
Rong Zhu   +12 more
wiley   +1 more source

Personas refugiadas, personas con agencia [Reseña]

open access: yes, 2019
[Resumen] Reseña de libro: Bradley, Megan; Milner, James y Peruniak, Blair (eds.). Refugees’ roles in resolving displacement and building peace. Beyond beneficiaries. Georgetown University Press, 2019. 321 págs.
openaire   +1 more source

Evaluation of KRAS and NRAS mutations in metastatic colorectal cancer: an 8‐year study of 10 754 patients in Turkey

open access: yesMolecular Oncology, EarlyView.
This nationwide study evaluated KRAS and NRAS mutations in 10 754 Turkish patients with metastatic colorectal cancer. The results revealed a mutation frequency of 51.1%, with 46.6% having KRAS mutations, 4.5% having NRAS mutations, and 48.5% being wild‐type for both.
Gozde Kavgaci   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy